Scout | Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

This grant opportunity invites applications for research on cancer causes and early detection biomarkers using the biorepository resources from the PLCO Screening Trial. The biorepository provides quality blood samples collected before diagnosis and buccal cells, along with associated data like demographics, lifestyle, and clinical information. The research should focus on cancer risk analysis…

Source

Agency: National Institutes of Health

Program: SBIR

Dates

Opportunity Released: September 8, 2021

Application Window Closes: October 11, 2024

Open for Submission: September 8, 2021

Submission Deadline: October 11, 2024

Keywords

cancer research

early detection biomarkers

PLCO Biospecimens

cancer etiology

biorepository resources

genetic analyses

biochemical analyses

clinical data

prostate lung colorectal ovarian cancer

cancer risk analysis

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers